Complications 15 years after breast augmentation with polyacrylamide

Mauricio, 2006 Rauso, 2011, Polyacrylamide gel injection for treatment of human immunodeficiency virus-associated lipoatrophy: 18 months follow-up, Dermatol Surg, 37, 1584, 10.1111/j.1524-4725.2011.02131.x Patlazhan, 2013, Breast reconstruction and treatment algorithm for patients with complications after polyacrylamide gel injections: a 10-year experience, Aesthetic Plast Surg, 37, 312, 10.1007/s00266-012-0045-5 Pallua, 2010, A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients, Plast Reconstr Surg, 125, 1797, 10.1097/PRS.0b013e3181d18158 Narins, 2010, 12-Month controlled study in the United States of the safety and efficacy of a permanent 2.5% polyacrylamide hydrogel soft-tissue filler, Dermatol Surg, 36, 1819, 10.1111/j.1524-4725.2010.01736.x Cheng, 2002, Complications of breast augmentation with injected hydrophilic polyacrylamide gel, Aesthetic Plast Surg, 26, 375, 10.1007/s00266-002-2052-4 Unukovych, 2012, Polyacrylamide gel injections for breast augmentation: management of complications in 106 patients, a multicenter study, World J Surg, 36, 695, 10.1007/s00268-011-1273-6 Amin, 2004, Complications from injectable polyacrylamide gel, a new nonbiodegradable soft tissue filler, Dermatol Surg, 30, 1507 Qiao, 2005, Management for postoperative complications of breast augmentation by injected polyacrylamide hydrogel, Aesthet Plast Surg, 29, 156, 10.1007/s00266-004-0099-0 Xu, 2012, Tissue degeneration 7 years after breast augmentation with injected polyacrylamide hydrogel (PAAG), Aesthetic Plast Surg, 36, 160, 10.1007/s00266-011-9779-8